Screener
Pacira BioSciences, Inc. PCRX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Total other (expense) income, net | (1,904) | 6,716 |
| Income before income taxes | 4,998 | 8,706 |
| Income tax expense | (2,082) | (3,894) |
| Net income | $2,916 | $4,812 |
| Net income per common share: | ||
| Basic and diluted net income per common share | $0.07 | $0.10 |
| Weighted average common shares outstanding: | ||
| Basic | 40,461 | 46,275 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s net income?
- Pacira BioSciences, Inc. (PCRX) reported net income of $2.92M in Q1 2026.
- How has Pacira BioSciences, Inc.'s net income changed year-over-year?
- Pacira BioSciences, Inc.'s net income decreased by 39.4% year-over-year, from $4.81M to $2.92M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Pacira BioSciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude